High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells

Diabetes/Metabolism Research and Reviews

Volumn 16, Issue 1, 2000, Pages 26-32

  Frittitta, Lucia ^a   Sbraccia, Paolo ^b   Costanzo, Benedetta V ^a   Tassi, Vittorio ^c   D'Adamo, Monica ^b   Spampinato, Daniela ^a   Ercolino, Tonino ^c   Purrello, Francesco ^a   Tamburrano, Guido ^b   Vigneri, Riccardo ^a   Trischitta, Vincenzo ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Scientific Institute   (Italy)

Author keywords

Hyperinsulinemia; Insulin receptor tyrosine kinase activity; Insulin resistance; Insulinoma; PC 1 expression

Indexed keywords

GLUCOSE; GLYCOGEN; GLYCOPROTEIN; INSULIN; INSULIN RECEPTOR; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; AGED; ARTICLE; AUTOPHOSPHORYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; IMMUNOPRECIPITATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINOMA; ISOTOPE LABELING; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; SKELETAL MUSCLE; THIN LAYER CHROMATOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; GLYCOGEN; HUMANS; INSULIN; INSULIN RESISTANCE; INSULINOMA; KINETICS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MUSCLE, SKELETAL; PANCREATIC NEOPLASMS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; PYROPHOSPHATASES; RECEPTOR, INSULIN; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 0034105685     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(200001/02)16:1<26::AID-DMRR78>3.0.CO;2-N     Document Type: Article

References (29)

1. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1988; 1992; 15: 318-368.
3. Bogardus C. Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care 1993; 16 (Suppl): 228-231.
4. Taylor SI. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 1994; 43: 735-740.
5. Beck-Nielsen H, Groop LC. Metabolic and genetic characterisation of prediabetic states. J Clin Invest 1994; 94: 1714-1721.
6. Khan RC. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
7. Olefsky JM, Nolan JJ. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr 1995; 61 (Suppl): 980S-986S.
8. Haring HU. The insulin receptor signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 1991; 34: 848-861.
9. Trischitta V, Frittitta L, Vigneri R. Early molecular defects in human insulin resistance: studies in healthy subjects with low insulin sensitivity. Diabetes Metab Rev 1997; 13: 147-162.
10. Hotamisligil GS, Spiegelman BM. Tumor Necrosis Factor-α: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
11. Ahmad F, Considine RV, Goldstein BJ. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest 1995; 95: 2806-2812.
12. Considine RV, Nyce MR, Allen LE, et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycaemia. J Clin Invest 1995; 95: 2938-2944.
13. Maddux BA, Sbraccia P, Kumakura S, et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 1995; 373: 448-451.
14. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 1998; 161: 11-26.
15. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine-kinase and whole body insulin sensitivity. Diabetologia 1996; 39: 1190-1195.
16. Frittitta L, Youngren J, Sbraccia P, et al. Increased adipose tissue PC-1 protein content, but not Tumor Necrosis Factor-α: gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997; 40: 282-289.
17. Youngren J, Maddux BA, Sasson S, et al. Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 1996; 45: 2-6.
18. Whitehead JP, Humphreys PJ, Dib K, Goding JW. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance. Clinical Endocrinol (Oxf) 1997; 47: 65-70.
19. Sbraccia P, D'Adamo M, Leonetti F, et al. Chronic primary hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 1996; 39: 220-225.
20. Federici M, Lauro D, D'Adamo M, et al. Expression of insulin/ IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Diabetes 1998; 47: 87-92.
21. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
22. Frittitta L, Spampinato D, Solini A, et al. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects. Evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signalling. Diabetes 1998; 47: 1095-1100.
23. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1998; 72: 254-284.
24. Wells AM, Sutcliffe IC, Johnson AB, Taylor R. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects: evidence for an abnormality specific to glucose metabolism. Diabetes 1993; 42: 583-589.
25. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
26. Williams JF, Olefsky JM. Defective insulin receptor function in down-regulated HepG2 cells. Endocrinology 1990; 127: 1706-1717.
27. Del Prato S, Leonetti F, Simonson DC, Sheeham P, Matsuda M, De Fronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37: 1023-1025.
28. Sakoda H, Ogihara T, Anai M, et al. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes 1999; 48: 1365-1371.
29. Sbraccia P, Goodman PA, Maddux BA, et al. Production of inhibitor of insulin-receptor tyrosine kinase in fibroblast from patients with insulin resistance and NIDDM. Diabetes 1991; 40: 295-299.